Gene · 6573
Papers1,999
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,999
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NEDD4 ameliorates myocardial reperfusion injury by preventing macrophages pyroptosis. | Cell Commun Signal | 2023 | 36732831 | PubTator, text mining | PubMed |
| ENPP1 Immunobiology as a Therapeutic Target. | Clin Cancer Res | 2023 | 36719675 | PubTator, text mining | PubMed |
| Identification of Cell-Specific Differential DNA Methylation Associated With Methotrexate Treatment Response in Rheumatoid Arthritis. | Arthritis Rheumatol | 2023 | 36716083 | PubTator, text mining | PubMed |
| Peptides from human BNIP5 and PXT1 and non-native binders of pro-apoptotic BAK can directly activate or inhibit BAK-mediated membrane permeabilization. | Structure | 2023 | 36706751 | PubTator, text mining | PubMed |
| A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancer. | J Transl Med | 2023 | 36635710 | PubTator, text mining | PubMed |
| The role of STING signaling in central nervous system infection and neuroinflammatory disease. | WIREs Mech Dis | 2023 | 36632700 | PubTator, text mining | PubMed |
| MMS22L-TONSL functions in sister chromatid cohesion in a pathway parallel to DSCC1-RFC. | Life Sci Alliance | 2023 | 36622344 | PubTator, text mining | PubMed |
| Study on the relationship between genetic polymorphism of reductive folic acid carrier and the risk of neural tube defects. | Childs Nerv Syst | 2023 | 36538104 | PubTator, text mining | PubMed |
| Immunodeficiency associated with a novel functionally defective variant of SLC19A1 benefits from folinic acid treatment. | Genes Immun | 2023 | 36517554 | Swiss-Prot, curated | PubMed |
| Nutritional metabolism and cerebral bioenergetics in Alzheimer's disease and related dementias. | Alzheimers Dement | 2023 | 36479795 | PubTator, text mining | PubMed |
| Genetic aetiology of Down syndrome birth: novel variants of maternal DNMT3B and RFC1 genes increase risk of meiosis II nondisjunction in the oocyte. | Mol Genet Genomics | 2023 | 36447056 | PubTator, text mining | PubMed |
| The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review. | Oncogene | 2023 | 36434179 | PubTator, text mining | PubMed |
| SARS-CoV-2, HIV, and HPV: Convergent evolution of selective regulation of cGAS-STING signaling. | J Med Virol | 2023 | 36229923 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Homocysteine levels, genetic background, and cognitive impairment in Parkinson's disease. | J Neurol | 2023 | 36169739 | PubTator, text mining | PubMed |
| Xanthones from securidaca inappendiculata antagonizes the anti-rheumatic effect of methotrexate by inhibiting reduced folate carrier 1. | Immunopharmacol Immunotoxicol | 2023 | 35850595 | PubTator, text mining | PubMed |
| Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind. | Anticancer Agents Med Chem | 2023 | 35692151 | PubTator, text mining | PubMed |
| Cell Surface Engineering Enables Surfaceome Profiling. | ACS Chem Biol | 2023 | 35443134 | PubTator, text mining | PubMed |
| Hereditary Folate Malabsorption: A Rare Treatable Disorder with Hematological and Neurological Manifestations. | Ann Indian Acad Neurol | 2022 | 36911455 | PubTator, text mining | PubMed |
| A CRISPR Path to Finding Vulnerabilities and Solving Drug Resistance: Targeting the Diverse Cancer Landscape and Its Ecosystem. | Adv Genet (Hoboken) | 2022 | 36911295 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6573/papers?page=12